This pathway provides guidance to aid providers in determining if a blood culture is indicated in a PICU/PCU patient with a fever (temperature > 38.5°C).

The clinical pathway for child with fever guides early identification, evaluation and management of patients with high-risk factors or severe signs/symptoms of disease.

The Outpatient Specialty Care and Primary Care Coronavirus Pathway provides guidance for the evaluation and care of patients with laboratory-confirmed 2019-nCoV or who is under investigation for 2019-nCoV while that patient was ill.

The ED Coronavirus Pathway provides guidance for the evaluation and care of patients with laboratory-confirmed 2019-nCoV or who is under investigation for 2019-nCoV while that patient was ill.

The Prevention of Acute Chemotherapy-Induced Nausea and Vomiting Clinical Pathway provides guidance for selecting anti-emetics and non-pharmacologic therapies for patients receiving chemotherapy.

Treatment of patients with active COVID-19 disease with guidance on severity of illness, recommendations for antivirals, steroids, immunomodulators, and convalescent plasma administration.

The PICU neonatal hyperammonemia pathway guides the care for infants < 30 days of age referred or presenting to CHOP for acute care for any abnormal or elevated ammonia level.

The Beckwith-Wiedemann Syndrome (BWS) Clinical Pathway provides guidance of care for neonates/infants born at the CHOP SDU or referred from outside institutions for further evaluation and treatment with overgrowth features such as macroglossia, hyperinsulinism, omphalocele and/or a constellation of findings suspicious for BWS.

The neonatal abstinence syndrome (NAS)/neonatal opioid withdrawal syndrome (NOWS) clinical pathway provides a care plan to optimize non-pharmacologic management for infants and maximize maternal-infant bonding

This pathway should be used to guide staff in recognizing and responding patients presenting with acute behavioral escalations in the Primary Care and Ambulatory Specialty Care locations.